Bone Biologics Corporation (BBLG) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.7M |
| Enterprise Value | -3.63M |
| P/E Ratio | -0.8 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.49 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.78 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.57 |
| Return On Equity | -0.5 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -3.11M |
| Net Income | -3.11M |
| Diluted EPS | -2.65 |
| Total Cash | 4.53M |
| Total Cash/Share | 2.52 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 16.09 |
| Book Value Per Share | 2.6 |
| 52-Week Change | -74.13 |
| 52-Week High | 6.75 |
| 52-Week Low | 1.05 |
| Moving Average 50 Days | 1.28 |
| Moving Average 200 Days | 1.66 |
| Average Volume | 12,685 |
| Shares Outstanding | 1.8M |
| % Held by Institutions | 0.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | June 10, 2025 |